Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host investor meetings at the TD Cowen 45th Annual Healthcare Conference.
Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference
A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation.
In a report released today, Derick Ma from TD Cowen maintained a Buy rating on Wheaton Precious Metals (WPM – Research Report), with a price ...
AllianceBernstein (NYSE:AB) was downgraded at TD Cowen after Equitable Holdings (NYSE:EQH) announced a tender offer for up to ...
Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over ...
Textron (NYSE:TXT – Get Free Report) was upgraded by investment analysts at TD Cowen to a “hold” rating in a report released ...
TD Cowen was established in 1918 as a bond trading firm and quickly expanded into clearing and execution services. By the 1970s, it had carved a niche in railroad bonds and grown a solid research ...
Mit Blick auf den KI-Nachfrage-Ausblick lässt ein Bericht der Investmentbank TD Cowen aufhorchen: Microsoft hat demnach ...
Domino’s Pizza (NASDAQ:DPZ – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at TD Cowen in a ...
Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over ...
TD Cowen analyst Andrew Sherman raised the firm’s price target on Axon (AXON) to $725 from $700 and keeps a Buy rating on the shares. The firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback